<DOC>
	<DOCNO>NCT00908271</DOCNO>
	<brief_summary>The purpose study estimate absolute oral bioavailability dapagliflozin .</brief_summary>
	<brief_title>Study Absolute Oral Bioavailability Dapagliflozin Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male subject ( age 18 45 ) determine medical history , physical examination , 12lead electrocardiogram ( ECG ) , clinical laboratory evaluation eligible participate study Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination Participation radiolabeled investigational study drug trial within 12 month prior admission clinical facility Exposure significant radiation within 12 month prior admission clinical facility</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>